Therapy News and Research

RSS

Introducing CELLER8®: Revolutionising Wellness with PEMF Technology

Med-tech manufacturer, Bedfont® Scientific Ltd., launches new CELLER8® PEMF device with exclusive distributor, NewMed Ltd. at the Health Optimisation Summit 2023.

From Bedfont® Scientific Ltd 22 Jun 2023

The benefits and harms of screening and treatment for anxiety and the accuracy of instruments to detect anxiety among primary care patients

Researchers from the United States (U.S.) reviewed the risks and benefits of anxiety screening and treatment.

22 Jun 2023

Repurposing cancer drugs for malaria treatment

With malaria becoming increasingly drug-resistant, a team of UCF researchers is looking to use cancer drugs to accelerate the discovery of new life-saving therapies for the disease.

21 Jun 2023

Researchers take promising step forward in the battle against HIV

A multi-institutional research group led by researchers from Tokyo Medical and Dental University (TMDU) has made a significant and promising step forward in our ability to treat human immunodeficiency virus type 1 (HIV-1), the virus underlying acquired immunodeficiency syndrome (AIDS).

21 Jun 2023

Humor therapy may reduce depression and anxiety symptoms

An analysis of published studies suggests that humor therapy may lessen symptoms of depression and anxiety.

21 Jun 2023

Newborn screening for "bubble-baby" disease boosts survival of children

Screening newborns for severe combined immunodeficiency disease (SCID) significantly increases the survival of children after bone marrow transplantation, a new North American study finds.

21 Jun 2023

Low-level laser therapy and associated photobiomodulation is the most effective treatment for tinnitus

Low-level laser therapy and associated photobiomodulation is the most effective of the known treatments for tinnitus, according to a study comparing the main therapies in current use, conducted by Brazilian scientists affiliated with the Optics and Photonics Research Center.

21 Jun 2023

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Single mutation of the hepatitis E virus stands in the way of sofosbuvir drug's effectiveness

A single mutation stands in the way of a drug's effectiveness. Understanding it helps find new therapeutic approaches.

21 Jun 2023

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, "Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer."

21 Jun 2023

Study investigates the interplay between acute stress and placebo effects in nausea

Researchers investigated the interplay between acute stress and placebo effects on nausea.

21 Jun 2023

The effect of SGLT2 inhibitors in patients with heart failure and type 2 diabetes

Researchers assessed the impact of SGLT2 inhibitors on type 2 diabetes and heart failure patients in real-world clinical settings.

21 Jun 2023

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Researchers evaluated the effectiveness of diabetic diets containing D-allulose among type 2 diabetes patients.

21 Jun 2023

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Introducing widespread screening of newborns for a deadly disease called severe combined immunodeficiency, or SCID, followed by early treatment boosted the five-year survival rate of children with the disorder from 73% before the advent of screening to 87% since, researchers report.

20 Jun 2023

$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.

20 Jun 2023

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical trial reported in the New England Journal of Medicine.

20 Jun 2023

Targeting Phage Therapy 2023 showcased the progress and possibilities of phage therapy in future

The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters.

20 Jun 2023

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own according to University of Alberta research, providing hope for new treatments that combine immunotherapy with traditional surgery, chemotherapy or radiation.

20 Jun 2023

Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer

The key executive appointment supports the strategic, operational delivery of the Company’s product and partnership programs.

From Closed Loop Medicine 20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Therapy News and Research

Introducing CELLER8®: Revolutionising Wellness with PEMF Technology

The benefits and harms of screening and treatment for anxiety and the accuracy of instruments to detect anxiety among primary care patients

Repurposing cancer drugs for malaria treatment

Researchers take promising step forward in the battle against HIV

Humor therapy may reduce depression and anxiety symptoms

Newborn screening for "bubble-baby" disease boosts survival of children

Low-level laser therapy and associated photobiomodulation is the most effective treatment for tinnitus

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Single mutation of the hepatitis E virus stands in the way of sofosbuvir drug's effectiveness

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

Study investigates the interplay between acute stress and placebo effects in nausea

The effect of SGLT2 inhibitors in patients with heart failure and type 2 diabetes

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Targeting Phage Therapy 2023 showcased the progress and possibilities of phage therapy in future

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News